On February 5, 2020, the FTC announced two settlements totaling nearly $3.4 million against Quantum Wellness Botanical Institute, LLC and their principals for claims made to older adults that the “ReJuvenation” pill was an “anti-aging wonder drug.” For example, they represented that the pill could boost HGH levels and add stem cells to the body, thereby repairing age, cell, and heart attack damage; reversing deafness or blindness; and reversing damage from any disease, including Alzheimer’s, Parkinson’s, and Crohn’s disease. The FTC’s complaint alleged that, despite claims that the benefits of ReJuvenation were clinically and scientifically proven, the defendants had not conducted any such clinical trials, nor did any competent and reliable trials on the product exist. The federal court orders require the defendants to have human clinical testing to support future claims related to the treatment of any disease or health condition.
FTC Ends Fountain of Youth Claims by Sellers of ReJuvenation Pills
